Kala Bio, Inc. (KALA)
0.4065
+0.04
(+11.89%)
USD |
NASDAQ |
Feb 13, 16:00
0.4189
+0.01
(+3.05%)
After-Hours: 20:00
Kala Bio EPS Diluted (Quarterly) : -1.074 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Q32 Bio, Inc. | -0.6036 |
| PharmaCyte Biotech, Inc. | -1.238 |
| Belite Bio, Inc. | -0.6529 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.564M |
| Total Expenses (Quarterly) | 7.564M |
| Enterprise Value | 12.18M |
| Earnings Yield | -1.46K% |
| Normalized Earnings Yield | -1539.83 |